Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

May 2015 - FRMC

06/10/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Data has shown that medication therapy management (MTM) can improve patient outcomes. MTMs can be deployed by several av- enues including internal teams at health plans, retail pharmacy, and third-party MTM companies.
Data has shown that medication therapy management (MTM) can improve patient outcomes. MTMs can be deployed by several av- enues including internal teams at health plans, retail pharmacy, and third-party MTM companies.
Data has shown that medication...
06/10/2015
First Report Managed Care
06/10/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Long-acting injectable (LAI) antipsychotics are highly effective in the management of schizophrenia and associated with a number of potential advantages over oral antipsychotics. First-generation LAIs (LA1s) have been available for more than...
Long-acting injectable (LAI) antipsychotics are highly effective in the management of schizophrenia and associated with a number of potential advantages over oral antipsychotics. First-generation LAIs (LA1s) have been available for more than...
Long-acting injectable (LAI)...
06/10/2015
First Report Managed Care
06/10/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Multiple sclerosis is an unpredictable, disabling disease with no known cure. Several disease-modifying treatments exist to reduce disease activity and progression.
Multiple sclerosis is an unpredictable, disabling disease with no known cure. Several disease-modifying treatments exist to reduce disease activity and progression.
Multiple sclerosis is an...
06/10/2015
First Report Managed Care
06/10/2015

Jill Sederstrom

Jill Sederstrom
Autoimmune disorder patients taking injectable biologics had lower average monthly drug costs compared to patients taking infusion biologics, according to the results of a new study.
Autoimmune disorder patients taking injectable biologics had lower average monthly drug costs compared to patients taking infusion biologics, according to the results of a new study.
Autoimmune disorder patients...
06/10/2015
First Report Managed Care
06/10/2015

Jill Sederstrom

Jill Sederstrom
New drugs on the horizon for cystic fibrosis (CF) could result in better patient outcomes, but will likely come at a higher cost, according to a poster session at AMCP titled Cystic Fibrosis Prevalence and Total Cost of Care in a Commercially...
New drugs on the horizon for cystic fibrosis (CF) could result in better patient outcomes, but will likely come at a higher cost, according to a poster session at AMCP titled Cystic Fibrosis Prevalence and Total Cost of Care in a Commercially...
New drugs on the horizon for...
06/10/2015
First Report Managed Care

Department

Conference Insider
06/10/2015

Jill Sederstrom

Jill Sederstrom
A new study examining the impact of a recently implemented clinical prior authorization edit for attention deficit disorder (ADD) and attention deficit/hyperactivity disorder (ADHD) found that the edit costs increased at a significantly lower...
A new study examining the impact of a recently implemented clinical prior authorization edit for attention deficit disorder (ADD) and attention deficit/hyperactivity disorder (ADHD) found that the edit costs increased at a significantly lower...
A new study examining the impact...
06/10/2015
First Report Managed Care
Conference Insider
06/10/2015

Melissa D. Cooper

Melissa D. Cooper
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an...
06/10/2015
First Report Managed Care
Conference Insider
06/10/2015

Melissa D. Cooper

Melissa D. Cooper
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in...
06/10/2015
First Report Managed Care
Conference Insider
06/10/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Hypertriglyceridemia is elevated triglyceride concentration in the blood caused by genetics, obesity, medications, and acute alcohol use with fatty liver disease.
Hypertriglyceridemia is elevated triglyceride concentration in the blood caused by genetics, obesity, medications, and acute alcohol use with fatty liver disease.
Hypertriglyceridemia is elevated...
06/10/2015
First Report Managed Care

News

News
06/10/2015

Eileen Koutnik-Fotopoulos

Eileen Koutnik-Fotopoulos
Heart failure (HF) is the leading cause of rehospitalization in both men and women on Medicare and the underlying cause of >58,000 US deaths in 2011, according to the Centers for Disease Control and Prevention.
Heart failure (HF) is the leading cause of rehospitalization in both men and women on Medicare and the underlying cause of >58,000 US deaths in 2011, according to the Centers for Disease Control and Prevention.
Heart failure (HF) is the...
06/10/2015
First Report Managed Care

Advertisement

Advertisement

Advertisement